Approved for Intra-abdominal infections, Nosocomial pneumonia, Skin and skin structure infections. Piperacillin inhibits bacterial cell wall synthesis; tazobactam inhibits beta-lactamase enzymes that would otherwise inactivate piperacillin. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC pricing.
Loading full data from Know Your Drugs Institute…